Purpose: We evaluated the relationship of prostate-specific antigen (PSA) and obesity indices (weight, body mass index [BMI] and waist circumference [WC]) in Korean middle-aged men. Materials and Methods: From February to September 2013, 1,900 police men under 60 years old who participated in a prostate health screening program were included this cross-sectional study. All subjects underwent clinical examinations including weight, height, BMI, WC, fasting blood sugar, lipid profiles, estimated glomerular filtration rate (GFR), and PSA. Total prostate volume (TPV) was assessed clinically. Spearman correlation and multiple linear regression tests were performed to evaluate the obesity indices and PSA relationships. Results: The mean age was 52.0±4.7 years, and the mean PSA was 0.97±0.99 ng/mL. The PSA showed a significant positive correlation with the age (r=0.108, p＜0.01), TPV (r=0.349, p＜0.01), height (r=-0.052, p＜0.05), weight (r=0.186, p＜0.05), low-density lipoprotein cholesterol (r=0.056, p＜0.05), and GFR (r=-0.096, p＜0.01). All obesity indices including weight, BMI, and WC showed negative correlations with PSA (beta=-0.013, p＜0.001; beta=-0.039, p＜0.001; and beta=-0.010, p=0.005; respectively) in age and TPV-adjusted model. Conclusions: Common obesity indices (weight, BMI, and WC) were associated with lower PSA in Korean middle-aged population. Thus, an individual's degree of obesity should be considered when PSA is checked in the first prostate cancer screening of life. (Korean J Urol Oncol 2018;16:103-109)
INTRODUCTION
Prostate cancer (PCa) is a major cause of death and the second most frequently diagnosed malignancy among men in the world, accounting for about 15% of total cancer diagnoses. 1 In South Korea, PCa incidence has increased steadily, while its mortality rate has declined slowly, due to extension of life expectancy of Korean, trend of western dietary style, and increased PSA screening. 1 To date, the proven risk factors for PCa are age, race, family history, and genetic factors. The rapid economic growth of developing countries and the widespread western diet have changed the pattern of disease in Korean over the past decade.
The increase in obesity and metabolic syndrome in Korean population is a typical change. It was reported that obesity is strongly associated with the development of advanced PCa in a recent meta-analysis, indicating that acquired risk factors re- lated to life style are associated with aggressiveness and progression of PCa. In the study of United States, Gleason score 7 or more PCa had positive correlations with body mass index (BMI), waist circumference (WC), body fat mass and fat-free mass. 2 In addition, in large European cohort study, abdominal fat had been shown to increase the risk of advanced PCa. 2 A prospective cohort study in Australia revealed that weight, BMI and weight gain in adulthood were associated with the development of high risk PCa, but not with the all PCa risk. 3 In addition, recent some studies on Asian populations have shown that PSA is age-dependent, increasing gradually with age, but negatively correlated with BMI. It is usually thought to be due to hemodilution by increasing body fluid volume. 4 In addition to obesity, other components of metabolic syndrome are also known to be associated with the risk of PCa.
However, the relationship between lifestyle-related risk factors, such as dyslipidemia and diabetes, and the development and progression of PCa remains unclear and has not been concluded. Most of these studies had few cases and short follow-up periods. 5, 6 These factors influence the reliability of PSA and raise the probability of false positives in obese patients, raising questions about the usefulness of PSA screening. It is necessary to study obesity and other confounding factors for PSA level at this time as Koreans become aged and the obesity population increases.
Therefore, we studied the relationships between obesity indicators (weight, height, BMI, and WC), fasting blood sugar (FBS), lipid profiles, estimated glomerular filtration rate (GFR), and PSA in Korean men undergoing prostate health check-up including routine physical screening, transrectal ultrasonography, and digital rectal examination (DRE). The aim of this study was to determine whether obesity indices and confounding factors have effects on PSA.
MATERIALS AND METHODS

Study population
In this study, were excluded. In addition, men with pyuria or bacteriuria were also excluded. A total 1,687 men were included finally in the study (Fig. 1 ).
Assessment of obesity and prostate factors
Weight, height, and WC of population were measured at the hospital by a nurse during the medical examination. After subjects stood relaxed, with arms folded comfortably, WC was 
Statistical analysis
Statistical analyses were conducted with PASW Statistics 
RESULTS
Patient demographics
The baseline characteristics in this study population are illustrated in and beta=-0.010, p=0.005, respectively).
DISCUSSION
The incidence of PCa has increased not only in Korea but also globally, which is related to the aging of the population.
Diabetes, obesity and dyslipidemia are some of the adult dis- 10 In few studies, obesity was considered a risk factor for PCa, 11 and in others, it was a protective factor. 12 One interesting point is that the results of the study differed according to geographical locations. In North American, obesity was not related to the risk of PCa, and on the other hand, in
European and Australian studies, obesity generally increased the risk of PCa. 8 It is suspected that these regional differences are often due to the different national PSA screening rates. Unlike the United States, European countries tend not to routinely perform PSA screening.
As shown in our study, obesity tends to lower PSA levels.
Furthermore, in our study, weight, BMI and WC were negatively associated with serum PSA level independent of age and TPV. Although the relationship between PSA and PCa risk is currently unclear, many previous studies have shown negative correlations between PSA and various obesity-related indicators. In large studies in the United States, BMI was negatively correlated with PSA level after adjusting for age and race. 13 In addition, in studies conducted in Asia, BMI reported negative correlations with PSA level. Unlike previous studies, we analyzed many confounding factors that may affect PSA levels including TPV, FBS, and dyslipidemia. Furthermore, obesity-related indicators included 3 different indicators such as body weight, BMI, and WC.
The effect of obesity on PSA is often explained by mechanism of hemodilution. It means that obesity results in a decrease in the PSA level in the blood as plasma volume increases in the human body. This theory suggested that the concentration of PSA is due to the function of plasma volume as well as the role of PSA poured into the circulation. 14 There are other theories about PSA levels. It is so-called "steroid hormone metabolism hypothesis" that PSA levels are regulated by the concentration of steroid hormones. 14 According to this theory, obesity affects PSA levels through various pathways and can affect the levels of human hormones and growth factors such as estrogen, testosterone, leptin, insulin, and insulin-like growth factor-1 influencing prostate growth. 15 In obese men, the amount of adipose tissue is high, which can increase the activity of aromatase by raising cyclic estrogen levels. there is lesser chance of having a prostate biopsy. 16 In addition, it has been reported that obesity may promote PCa growth. In preclinical studies conducted to date, it is suspected that androgens promote PCa cell growth through the pathway of lipo- Whether diabetes itself has a protective effect against PCa or reduces PSA levels remains unclear issues. In our study, PSA level was not associated with FBS. However, in many studies, diabetes and the risk of PCa has been reported to be inversely correlated. A common hypothesis is that hyperinsulinemia lowers testosterone levels, which may lower the risk of PCa. 21 Unfortunately, the results of several studies were not consistent, and usually reported high prevalence of high-risk PCa in diabetic men. 22 Although the mechanism is somewhat lacking in understanding, the theory that insufficient testosterone is involved in the proliferation cycle of the prostate, induces abnormal epithelial differentiation, and changes cancer cells into more aggressive cells is considered worthwhile. 23 Some previous prospective studies have addressed the association between total cholesterol and high-risk PCa. 24 However, total cholesterol and PSA were not related in our study. Taken together, previous results suggested that total cholesterol have no significant effect on PSA levels. In recent large-scale study, triglycerides appeared to have an effect on the aggressiveness and severity of PCa. 25 In addition, in the in vitro studies, triglyceride-rich remnant lipoproteins have been promoted carcinogenesis according to up-regulating cellular signaling, such as MEK/ERK and Akt pathways, involved in modulating cell proliferation and growth, apoptosis, cell cycle arrest, and lipid biosynthesis. 26 One large study in China reported that triglycerides were inversely correlated to PSA levels. 27 However, this study did not find a relationship between triglyceride and PSA, and it seems that LDL cholesterol is weakly related to PSA.
Therefore, further studies for relationship between lipid and PSA should be studied in patients with PCa because most of the current research has been done from healthy population. However, according to the literature known to date, the aforementioned lifestyle-related factors are not considered to be associated with PSA levels.
In conclusion, this study found that several indices associated with obesity had an effect on PSA levels in Korean middle-aged men aged 38 to 60 years who underwent routine health examination, and these factors were independent of age and TPV. In the future, it may be necessary to provide reference values considering the effects of obesity indices for middle-aged men who perform PSA screening for the first time in life, unlike men aged 60 years or older.
